Proteomics of Uveal Melanomas Suggests HSP-27 as a Possible Surrogate Marker of Chromosome 3 Loss

被引:22
作者
Coupland, Sarah E. [1 ]
Vorum, Henrik [2 ,3 ]
Mandal, Nakul [3 ]
Kalirai, Helen [1 ]
Honore, Bent [3 ]
Urbak, Steen Fiil [2 ]
Lake, Sarah L. [1 ]
Dopierala, Justyna [1 ]
Damato, Bertil [4 ]
机构
[1] Univ Liverpool, Dept Pathol, Sch Canc Studies, Liverpool L69 3BX, Merseyside, England
[2] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark
[3] Aarhus Univ, Dept Med Biochem, Aarhus, Denmark
[4] Royal Liverpool Univ Hosp, Ocular Oncol Serv, St Pauls Eye Clin, Liverpool, Merseyside, England
基金
英国医学研究理事会;
关键词
SHOCK-PROTEIN EXPRESSION; HSP27; CANCER; CELLS; METASTASIS; PHENOTYPE; CARCINOMA; VIMENTIN; SURVIVAL; IDENTIFICATION;
D O I
10.1167/iovs.09-3913
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To compare the proteomic profiles of primary uveal melanomas, with and without loss of chromosome 3. METHODS. Frozen specimens from three uveal melanomas with disomy 3 and from four tumors with monosomy 3, according to fluorescence in situ hybridization (FISH) analysis, were subjected to high-resolution, two-dimensional (2-D) gel electrophoresis. The protein expression profiles of the two uveal melanoma cytogenetic groups were compared: Proteins that differed significantly were excised and analyzed by tandem mass spectrometry. Differentially expressed proteins were further analyzed with Western blot analysis. An independent cohort of 41 formalin-fixed, paraffin-embedded (FFPE) uveal melanomas, whose chromosome 3 status had been determined by multiplex ligation-dependent probe amplification (MLPA), was examined for the appropriate antigens by immunohistochemistry. RESULTS. Four protein spots were 1.5-fold (Student's t-test, P < 0.05) differentially expressed in the two uveal melanoma types: two spots were overexpressed in the disomy 3 group compared with the monosomy 3 group, whereas two spots were underexpressed. Identification of the four spots yielded nine proteins. Western blot analysis confirmed the results for heat shock protein (HSP)-27, vimentin, and pyruvate dehydrogenase beta(PDHB), with a statistical significance for the first two proteins. HSP-27 was significantly downregulated, whereas vimentin was upregulated in the monosomy 3 tumors (Student's t-test, P = 0.003 and P = 0.005, respectively). Immunohistochemistry confirmed low-to-negative HSP-27 protein expression in monosomy 3 uveal melanomas (Student's t-test; P = 0.011). CONCLUSIONS. Low-to-negative HSP-27 protein expression in uveal melanoma correlates strongly with monosomy 3. Further validation is necessary to determine whether immunohistochemical assessment of HSP-27 expression correlates with metastatic mortality. (Invest Ophthalmol Vis Sci. 2010; 51: 12-20) DOI: 10.1167/iovs.09-3913
引用
收藏
页码:12 / 20
页数:9
相关论文
共 33 条
[1]  
Aldrian S, 2002, CELL STRESS CHAPERON, V7, P177, DOI 10.1379/1466-1268(2002)007<0177:OOHATM>2.0.CO
[2]  
2
[3]  
Cornford PA, 2000, CANCER RES, V60, P7099
[4]   Artifficial neural networks estimating survival probability after treatment of choroidal melanoma [J].
Damato, Bertil ;
Eleuteri, Antonio ;
Fisher, Anthony C. ;
Coupland, Sarah E. ;
Taktak, Azzam F. G. .
OPHTHALMOLOGY, 2008, 115 (09) :1598-1607
[5]   Cytogenetics of uveal melanoma - A 7-year clinical experience [J].
Damato, Bertil ;
Duke, Catherine ;
Coupland, Sarah E. ;
Hiscott, Paul ;
Smith, Peter A. ;
Campbell, Ian ;
Douglas, Angela ;
Howard, Peter .
OPHTHALMOLOGY, 2007, 114 (10) :1925-1931
[6]   Treatment of primary intraocular melanoma [J].
Damato, Bertil .
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (04) :493-506
[7]   Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death [J].
Damato, Bertil ;
Dopierala, Justyna ;
Klaasen, Annelies ;
van Dijk, Marcory ;
Sibbring, Julie ;
Coupland, Sarah E. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (07) :3048-3055
[8]  
FUCHS U, 1992, AM J PATHOL, V141, P169
[9]  
Geisler JP, 2004, EUR J GYNAECOL ONCOL, V25, P165
[10]   Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer [J].
Ghadjar, P ;
Coupland, SE ;
Na, IK ;
Noutsias, M ;
Letsch, A ;
Stroux, A ;
Batter, S ;
Buhr, HJ ;
Thiel, E ;
Scheibenbogen, C ;
Keilholz, U .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) :1910-1916